US FDA grants orphan drug designation to Enalare’s ENA-001
06 Oct 2022 //
PHARMABIZ
Eagle and Enalare Therapeutics Announce FDA Orphan Drug Designation for ENA-001
03 Oct 2022 //
GLOBENEWSWIRE
New Jersey biotech nets $50M+ BARDA contract for respiratory candidate
27 Sep 2022 //
ENDPTS
Eagle Pharma Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics
09 Aug 2022 //
GLOBENEWSWIRE
NIH Grants $2.8m to Help Startup Advance Second-Generation Breathing Stimulant
03 Jul 2022 //
TRIALSITENEWS